EP1331930A4 - Procedes et compositions pour reguler la consolidation de la memoire - Google Patents
Procedes et compositions pour reguler la consolidation de la memoireInfo
- Publication number
- EP1331930A4 EP1331930A4 EP01924598A EP01924598A EP1331930A4 EP 1331930 A4 EP1331930 A4 EP 1331930A4 EP 01924598 A EP01924598 A EP 01924598A EP 01924598 A EP01924598 A EP 01924598A EP 1331930 A4 EP1331930 A4 EP 1331930A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- compositions
- methods
- memory consolidation
- regulating memory
- regulating
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
- G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
- G01N2333/4701—Details
- G01N2333/4703—Regulators; Modulating activity
- G01N2333/4706—Regulators; Modulating activity stimulating, promoting or activating activity
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/575—Hormones
- G01N2333/65—Insulin-like growth factors (Somatomedins), e.g. IGF-1, IGF-2
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
- G01N2333/70571—Assays involving receptors, cell surface antigens or cell surface determinants for neuromediators, e.g. serotonin receptor, dopamine receptor
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Neurology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicinal Chemistry (AREA)
- Neurosurgery (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Biomedical Technology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Immunology (AREA)
- Analytical Chemistry (AREA)
- Wood Science & Technology (AREA)
- Hospice & Palliative Care (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Psychiatry (AREA)
- Pathology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Marine Sciences & Fisheries (AREA)
- Gastroenterology & Hepatology (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US19361400P | 2000-03-31 | 2000-03-31 | |
US193614P | 2000-03-31 | ||
PCT/US2001/010661 WO2001074298A2 (fr) | 2000-03-31 | 2001-04-02 | Procedes et compositions pour reguler la consolidation de la memoire |
Publications (2)
Publication Number | Publication Date |
---|---|
EP1331930A2 EP1331930A2 (fr) | 2003-08-06 |
EP1331930A4 true EP1331930A4 (fr) | 2003-08-06 |
Family
ID=22714335
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP01924598A Withdrawn EP1331930A4 (fr) | 2000-03-31 | 2001-04-02 | Procedes et compositions pour reguler la consolidation de la memoire |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP1331930A4 (fr) |
JP (1) | JP2004508288A (fr) |
AU (1) | AU2001251242A1 (fr) |
WO (1) | WO2001074298A2 (fr) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6689557B1 (en) * | 1994-10-07 | 2004-02-10 | Cold Spring Harbor Laboratory | Method of identifying a substance that affects long term memory and CREM/CREB/ATF-1 subfamily members |
WO2002052042A2 (fr) * | 2000-12-22 | 2002-07-04 | Medical Research Council | Procede d'analyse de composes |
WO2003060516A1 (fr) * | 2002-01-10 | 2003-07-24 | Takeda Chemical Industries, Ltd. | Methode de criblage |
AUPS255202A0 (en) * | 2002-05-27 | 2002-06-13 | Monash University | Agents and methods for the treatment of disorders associated with motor neuron degeneration |
US20060040338A1 (en) * | 2004-08-18 | 2006-02-23 | Odyssey Thera, Inc. | Pharmacological profiling of drugs with cell-based assays |
US20060094059A1 (en) * | 2004-09-22 | 2006-05-04 | Odyssey Thera, Inc. | Methods for identifying new drug leads and new therapeutic uses for known drugs |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1997046257A1 (fr) * | 1996-06-03 | 1997-12-11 | The Trustees Of Columbia University In The City Of New York | Procede permettant d'ameliorer la memoire a long terme chez un sujet et utilisations de ce procede |
WO2001068137A2 (fr) * | 2000-03-14 | 2001-09-20 | Brown University Research Foundation | Procedes et preparations pour la regulation de la consolidation de la memoire |
-
2001
- 2001-04-02 WO PCT/US2001/010661 patent/WO2001074298A2/fr not_active Application Discontinuation
- 2001-04-02 AU AU2001251242A patent/AU2001251242A1/en not_active Abandoned
- 2001-04-02 EP EP01924598A patent/EP1331930A4/fr not_active Withdrawn
- 2001-04-02 JP JP2001572044A patent/JP2004508288A/ja not_active Withdrawn
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1997046257A1 (fr) * | 1996-06-03 | 1997-12-11 | The Trustees Of Columbia University In The City Of New York | Procede permettant d'ameliorer la memoire a long terme chez un sujet et utilisations de ce procede |
WO2001068137A2 (fr) * | 2000-03-14 | 2001-09-20 | Brown University Research Foundation | Procedes et preparations pour la regulation de la consolidation de la memoire |
Non-Patent Citations (3)
Title |
---|
DATABASE BIOSIS [online] BIOSCIENCES INFORMATION SERVICE, PHILADELPHIA, PA, US; February 1999 (1999-02-01), ALEMAN ANDRE ET AL: "Insulin-like growth factor-I and cognitive function in healthy older men.", XP002241280, Database accession no. PREV199900133267 * |
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, vol. 84, no. 2, February 1999 (1999-02-01), pages 471 - 475, ISSN: 0021-972X * |
RICKARD, N. S. ET AL: "Blockade of metabotropic glutamate receptors prevents long - term memory consolidation", BRAIN RESEARCH BULLETIN (1995), 36(4), 355-9, XP002241279 * |
Also Published As
Publication number | Publication date |
---|---|
JP2004508288A (ja) | 2004-03-18 |
WO2001074298A3 (fr) | 2003-05-22 |
AU2001251242A1 (en) | 2001-10-15 |
EP1331930A2 (fr) | 2003-08-06 |
WO2001074298A2 (fr) | 2001-10-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU3946402A (en) | Methods and compositions for regulating memory consolidation | |
AU2001239947A1 (en) | Methods and compositions for regulating adipocytes | |
AU2001285409A1 (en) | Memory devices and methods for use therewith | |
PL351552A1 (en) | Gypsum compositions and related methods | |
IL154217A0 (en) | Indazole derivatives as jnk ingibitors and compositions and methods related thereto | |
EP1176948A4 (fr) | Compositions et methodes antinauseeuses | |
PL364079A1 (en) | Arylsulfatase-inhibitors in deodorants and antiperspirants | |
EP1299068A4 (fr) | Compositions dermatologiques soufrees et procedes de reduction des mauvaises odeurs dans des compositions dermatologiques | |
AU6832101A (en) | Composition and method | |
EG23005A (en) | Deodorant and/or antiperspirant compositions | |
AU4163402A (en) | Composition and method | |
GB0020201D0 (en) | Cosmetic Composition | |
IL154422A0 (en) | Paroxetine compositions and processes for making the same | |
AU7311501A (en) | Cosmetic composition and method | |
AU2452502A (en) | Compositions for regulating desire for smoking | |
HU0104832D0 (en) | Cosmetic composition and method | |
AU4215901A (en) | Methods and compositions for immunoregulation | |
IL154267A0 (en) | Neuroprotective 2-pyridinamine compositions and related methods | |
AU2001243635A1 (en) | Methods and compositions for regulating memory consolidation | |
AU2001275409A1 (en) | Methods and compositions for controlled polypeptide synthesis | |
EP1331930A4 (fr) | Procedes et compositions pour reguler la consolidation de la memoire | |
EP1277459A4 (fr) | Compositions de frisage et methode de frisage utilisant ces compositions | |
IL145289A0 (en) | Method and compositions for regulating memory consolidation | |
HK1077767A1 (en) | Deodorant compositions | |
AU1182402A (en) | Methods and compositions for enhancing angiogenesis |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20021029 |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 20030604 |
|
AK | Designated contracting states |
Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR |
|
17Q | First examination report despatched |
Effective date: 20030922 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20040403 |